Insider Transactions in Q4 2025 at Cvs Health Corp (CVS)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2025
|
James David Clark SVP, Cont & Chief Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
220
-0.89%
|
$17,380
$79.1 P/Share
|
|
Nov 30
2025
|
Roger N Farah Director |
SELL
Payment of exercise price or tax liability
|
Direct |
9,748
-33.4%
|
$779,840
$80.36 P/Share
|
|
Nov 30
2025
|
Tilak Mandadi EVP, Chief Exp & Tech Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,575
-8.15%
|
$526,000
$80.36 P/Share
|
|
Nov 30
2025
|
Heidi B Capozzi EVP and Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,470
-45.34%
|
$757,600
$80.36 P/Share
|
|
Nov 20
2025
|
Guy P Sansone Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,652
+10.79%
|
$125,552
$76.04 P/Share
|
|
Nov 20
2025
|
Douglas H. Shulman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,652
+21.79%
|
$125,552
$76.04 P/Share
|
|
Nov 20
2025
|
Anne A. Finucane Director |
BUY
Grant, award, or other acquisition
|
Direct |
591
+50.0%
|
$44,916
$76.04 P/Share
|
|
Nov 20
2025
|
J Scott Kirby Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,652
+11.28%
|
$125,552
$76.04 P/Share
|
|
Nov 20
2025
|
Leslie V Norwalk Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,652
+21.79%
|
$125,552
$76.04 P/Share
|
|
Nov 20
2025
|
Fernando Aguirre Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,800
+4.21%
|
$136,800
$76.04 P/Share
|
|
Nov 20
2025
|
Jeffrey R. Balser Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,775
+11.5%
|
$134,900
$76.04 P/Share
|
|
Nov 20
2025
|
C David Brown Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,775
+1.37%
|
$134,900
$76.04 P/Share
|